- Home
- CMPS vs AEYE Comparison
CMPS vs AEYE Comparison
Compare CMPS & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- AEYE
- Stock Information
- Founded
- CMPS 2020
- AEYE 2005
- Country
- CMPS United Kingdom
- AEYE United States
- Employees
- CMPS N/A
- AEYE N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- AEYE Computer Software: Prepackaged Software
- Sector
- CMPS Health Care
- AEYE Technology
- Exchange
- CMPS Nasdaq
- AEYE Nasdaq
- Market Cap
- CMPS 301.7M
- AEYE 278.0M
- IPO Year
- CMPS 2020
- AEYE N/A
- Fundamental
- Price
- CMPS $4.10
- AEYE $20.70
- Analyst Decision
- CMPS Strong Buy
- AEYE Strong Buy
- Analyst Count
- CMPS 7
- AEYE 4
- Target Price
- CMPS $30.67
- AEYE $30.13
- AVG Volume (30 Days)
- CMPS 972.1K
- AEYE 292.7K
- Earning Date
- CMPS 10-31-2024
- AEYE 11-07-2024
- Dividend Yield
- CMPS N/A
- AEYE N/A
- EPS Growth
- CMPS N/A
- AEYE N/A
- EPS
- CMPS N/A
- AEYE N/A
- Revenue
- CMPS N/A
- AEYE $33,348,000.00
- Revenue This Year
- CMPS N/A
- AEYE $14.64
- Revenue Next Year
- CMPS N/A
- AEYE $21.65
- P/E Ratio
- CMPS N/A
- AEYE N/A
- Revenue Growth
- CMPS N/A
- AEYE 6.94
- 52 Week Low
- CMPS $4.00
- AEYE $4.01
- 52 Week High
- CMPS $12.75
- AEYE $34.85
- Technical
- Relative Strength Index (RSI)
- CMPS 29.41
- AEYE 37.37
- Support Level
- CMPS $4.34
- AEYE $25.52
- Resistance Level
- CMPS $4.66
- AEYE $28.50
- Average True Range (ATR)
- CMPS 0.32
- AEYE 1.78
- MACD
- CMPS -0.00
- AEYE -0.46
- Stochastic Oscillator
- CMPS 4.66
- AEYE 5.45
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's, and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.